Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3069 participants
OBSERVATIONAL
2022-06-01
2022-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
For daily clinical practice, it would be better if dangerous changes in vital signs could be predicted. In this case, it would be possible to intervene therapeutically not only when a dangerous situation has arisen, but to try to avert this situation through adequate measures by changing the therapy strategy. In such a case, the treatment team would no longer be confronted with emergency alarms, but could counteract an impending deterioration with a long lead time.
The first approaches for detecting a drop in blood pressure, for example, which are based on simple models, are already in clinical use.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Focused TTE for Hemodynamic Instable High Risk Patients
NCT01811914
Prediction of Outcome by Echocardiography in Left Bundle Branch Block
NCT04293471
Real-time Continuous Cardiac Output Measurements
NCT04774978
FLuid Responsiveness Prediction Using EXtra Systoles
NCT03002129
Biventricular Epicardial Pacing Post Cardiac Surgery in Patients With Left Ventricular Ejection Fractions Less Than 45%
NCT00604110
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Instability
Machine Learning Prediction
Machine Learning Prediction
No Instability
Machine Learning Prediction
Machine Learning Prediction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Machine Learning Prediction
Machine Learning Prediction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kepler University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Tschoellitsch, MD
Role: PRINCIPAL_INVESTIGATOR
Kepler University Hospital and Johannes Kepler University, Linz, Austria
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kepler University Hospital
Linz, Upper Austria, Austria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tschoellitsch T, Kaltenleithner S, Maletzky A, Moser P, Seidl P, Bock C, Thumfart S, Giretzlehner M, Hochreiter S, Meier J. Mean arterial pressure is all you need in a machine learning model for mean arterial pressure prediction. Eur J Anaesthesiol. 2025 Jul 8. doi: 10.1097/EJA.0000000000002238. Online ahead of print.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRECAIN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.